Funded Tech Companies

HBM Alpha Therapeutics

HBM Alpha Therapeutics raised its funding from Harbour BioMed.

Company Overview

Company Name
HBM Alpha Therapeutics
Company Status
Private & Independent
Funding Rounds
Total Funding

Contact Information

Mailing Address
Undisclosed
Undisclosed, DE Undisclosed
USA
Phone
Undisclosed
Email Address

Company Background Information

Overview
Harbour BioMed (HKEX: 02142) is a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immunology and oncology. The Company is building its robust portfolio and differentiated pipeline through internal R&D capability, collaborations with co-discovery and co-development partners and select acquisitions.
Profile
HBM Alpha Therapeutics LinkedIn Company Profile
Social Media
HBM Alpha Therapeutics Company Twitter Account
Company News
HBM Alpha Therapeutics News
Facebook
HBM Alpha Therapeutics on Facebook
YouTube
HBM Alpha Therapeutics on YouTube
Last Transaction
1/26/2023

Financing History

Date
Type
Amount
Venture Equity
Unknown


Management Team

Title
Name
Email & Social
Chairman
Jingsong Wang
  Jingsong Wang LinkedIn Profile  Jingsong Wang Twitter Account  Jingsong Wang News  Jingsong Wang on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

HBI Solutions | HBOX Therapies

 

Share this article

 


About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary